About trainings

The objective of MPP is to support synergies between the pharma, medtech, and tech industries by establishing a forum to exchange knowledge and collaborate in the areas of technology and regulatory policy, while building stakeholder consensus to promote product development and innovation.

To this aim,  MPP dispenses accredited trainings throughout the year in addition to its annual meeting.

Target audience: Professionals and individuals in the pharma, medtech and tech sectors.

Topics: The topics are varied, but broadly cover industry, regulatory and technical developments.

Course leaders: All trainings are given by topic experts.

SwAPP accreditation: Training courses organized by MPP are accredited by the Swiss Association of Pharmaceutical Professionals (SwAPP). Participants in the training courses can receive SwAPP credits.

Past training courses & webinars

In einem Meeting

24 June 2021, 2:00-5:00 pm CEST

Development and regulatory considerations for connected combined products

ShayestehFuerst2.jpg

Shayesteh Fürst-Ladani, MPP

SFL CEO and MPP President

OIiver Shergold.jpg

Oliver Shergold, Novartis

Head of Ecosystem Operations

Tomaso Scherini.jpg

Tomaso Scherini, Philips Engineering Solutions

Business Partner

Abtin Rad.jpg

Abtin Rad, TÜV SÜD

Global Director Functional Safety

Christiana Hofmann.jpg

Christiana Hofmann, TÜV SÜD

Regional Manager Focus Topics Article 117 & Annex XVI MDR

In einem Meeting

26 May 2021, 1:00-3:45 pm CEST

Introduction to clinical evaluation under the MDR

ShayestehFuerst2.jpg

Shayesteh Fürst-Ladani

SFL CEO and MPP President

Marta.jpg

Marta Swierczynska, SFL

Senior Manager Regulatory Affairs

Patricia.jpg

Patricia McHugh Giordano, MSD

Executive Director, Medical Safety Lead for Devices and Product Quality

Joshua.jpg

Joshua Samuels, Johnson & Johnson

Director of Clinical Evaluations

Alice.jpg

Alice Genevet, SFL

Senior Manager Medical Affairs & Regulatory Affairs

Ulrich.jpg

Ulrich Nitsche, TÜV-SÜD

Clinical Reviewer

In einem Meeting

27 April 2021, 3:00-4:00 pm CEST /

2:00-3:00 pm GMT

Joint webinar MPP / UK Department for International Trade in Switzerland

ShayestehFuerst2.jpg

Shayesteh Fürst-Ladani

SFL CEO and MPP President

Helen Stubbs.jpg

Helen Stubbs, UK Department for International Trade in Switzerland

Senior Inward Investment Officer

Nei Ebenezer.jpg

Neil Ebenezer, UK Department for International Trade

Medtech Senior Specialist Advisor

Alex-Mclaughlin-300x225-300x225.jpg

Alex Mclaughlin, UK Office for Life Sciences (OLS)

Head of International Trade and Medical Device Regulation

In einem Meeting

16 February 2021

Virtual Training Course

Introduction to the EU MDR art. 117 and single integral drug/device combination products

ShayestehFuerst2.jpg

Shayesteh Fürst-Ladani

SFL CEO and MPP President

Image_S2_Ypsomed(MPP)_AffolterS.JPG

Stephan Affolter, Ypsomed

Regulatory and Quality Intelligence Manager

Hofmann.png

Christiana Hofmann, TÜV-SÜD

Teamlead Non Active Medical Devices / Article 117 MDR

b093d401-5726-47f5-948b-34aed9e63997.jpg

Mike Wallenstein, Novartis

Global Head MDR Implementation & DD&C Compliance